The growth rate of pharmaceutical industry is stable, and the recovery of specialty drugs is concerned

[market analysis of chinapharma.com] from January to July 2017, the revenue growth of the pharmaceutical industry picked up steadily According to the data of the National Bureau of statistics, the revenue of the pharmaceutical manufacturing industry increased by 11.9% year on year from January to July And in the development process of pharmaceutical industry, specialized drug manufacturers are focused on The National Bureau of Statistics recently released the economic data of major industries from January to July 2017 The revenue of pharmaceutical manufacturing industry increased by 11.9% to RMB 1707.3 billion, and the total profit increased by 18.7% to RMB 1.875 billion In general, the growth of pharmaceutical industry showed a steady recovery In order to guide the healthy development of the industry and ensure the long-term sustainable operation of the medical insurance fund, the government has implemented medical insurance fee control, bidding price reduction, restrictions on auxiliary drugs, control of the proportion of hospital drugs and so on in the past few years, resulting in a significant decline in the growth rate of the pharmaceutical industry's income Since 2017, the government has not issued any more stringent policies, and the financial sector has been encouraging the development of innovative drugs, so the growth rate of the industry has picked up steadily After the implementation of the new national medical insurance catalogue, the sales volume will gradually increase The Ministry of human resources and social security of the people's Republic of China released the new version of the national medical insurance catalogue in February 2017 According to our statistics, at present, 14 provinces have announced that they will start to implement the national medical insurance catalogue on September 1, namely Jiangsu, Liaoning, Anhui, Henan, Xinjiang, Jilin, Inner Mongolia, Fujian, Shandong, Zhejiang, Hunan, Jiangxi, Hubei and Beijing Generally speaking, the progress is slightly slower than the market expectation, However, the government originally required all regions to complete the adjustment by July 31, so we expect more provinces to announce the specific implementation time within the year From the specific content of the new version of the national medical insurance catalog released in February, the newly added categories are mainly specialized drugs with broad market demand such as cardio cerebrovascular and tumor We believe that with the implementation of the new version of the national health insurance catalog, the sales volume of the new selected varieties will be improved The speed of drug consistency review is accelerated, which is beneficial to high-quality specialty drug manufacturers The State Food and Drug Administration recently announced the announcement on the issues related to the consistency evaluation of quality and efficacy of generic drugs (No 100, 2017), which clearly proposed the time limit for consistency evaluation, that is, the evaluation should be completed within 120 days after acceptance If it is considered that supplementary information is needed, the applicant shall complete the supplementary information in one time within 4 months In March 2016, the government issued the opinions on the evaluation of the quality and efficacy of generic drugs, and began to implement the consistency review In principle, the reference preparation requires the original research drug, or the internationally recognized same kind of drug We believe that the acceleration of drug consistency review will promote the survival of the fittest in the industry, and in the long run, it will be conducive to the development of the leading pharmaceutical industry with strong R & D capabilities Focus on Shiyao group (1093 HK) and dongyangyao (1558 HK) Looking back on the policy orientation of the domestic pharmaceutical industry in the past two years, we believe that the government, on the one hand, has been focusing on improving the industry standards by requiring hospitals to reduce the proportion of drugs, replacing business tax with value-added tax, etc., on the other hand, the government has been focusing on improving the industry standards, and drug consistency review is one of the important policies, The selection criteria for the new version of the national medical insurance catalogue also focus on specialty drugs Original title: Pharmaceutical Industry: focus on specialty drug manufacturers Seize the opportunity of pharmaceutical machinery and equipment industry, please download app (Pharma, Android version)!